The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists

The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists
复制标题

DOI:
10.15252/embj.201696164
复制
发表时间:
2018-01-04
期刊:
影响因子:
11.4
通讯作者:
Fingar, Diane C.
Fingar, Diane C.
中科院分区:
生物学1区
文献类型:
--
作者:
Bodur, Cagri;Kazyken, Dubek;Fingar, Diane C.

文献摘要

被引文献

相似文献

先天免疫激酶TBK1通过驱动I型干扰素的产生来启动对抗感染性病原体的炎症反应。TBK1还控制代谢过程,促进癌基因诱导的细胞增殖和存活。在这里,我们证明TBK1直接激活mTOR复合物1 (mTORC1)。在培养的细胞中,TBK1通过特定位点的mTOR磷酸化(在S2159上)与mTORC1结合并激活mTORC1,以响应某些生长因子受体(即egf受体,但不包括胰岛素受体)和病原体识别受体(即TLR3; TLR4),揭示TBK1在mTORC1调节中的刺激选择性作用。通过研究培养的巨噬细胞和从基因组编辑的mTOR S2159A敲入小鼠中分离的巨噬细胞,我们发现mTOR S2159磷酸化促进mTORC1信号传导、IRF3核易位和ifn - β的产生。这些数据表明TBK1和mTORC1功能之间存在直接的机制联系,以及TBK1-mTORC1轴在控制先天免疫功能中的生理意义。这些数据揭示了TBK1作为mTORC1的直接激活剂,并提示TBK1下游的mTORC1在先天免疫、肿瘤发生和慢性炎症相关疾病的控制中具有意想不到的作用。
The innate immune kinase TBK1 initiates inflammatory responses to combat infectious pathogens by driving production of type I interferons. TBK1 also controls metabolic processes and promotes oncogene-induced cell proliferation and survival. Here, we demonstrate that TBK1 activates mTOR complex 1 (mTORC1) directly. In cultured cells, TBK1 associates with and activates mTORC1 through site-specific mTOR phosphorylation (on S2159) in response to certain growth factor receptors (i.e., EGF-receptor but not insulin receptor) and pathogen recognition receptors (PRRs) (i.e., TLR3; TLR4), revealing a stimulus-selective role for TBK1 in mTORC1 regulation. By studying cultured macrophages and those isolated from genome edited mTOR S2159A knock-in mice, we show that mTOR S2159 phosphorylation promotes mTORC1 signaling, IRF3 nuclear translocation, and IFN-beta production. These data demonstrate a direct mechanistic link between TBK1 and mTORC1 function as well as physiologic significance of the TBK1-mTORC1 axis in control of innate immune function. These data unveil TBK1 as a direct mTORC1 activator and suggest unanticipated roles for mTORC1 downstream of TBK1 in control of innate immunity, tumorigenesis, and disorders linked to chronic inflammation.